Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.38 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.38 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.38 |
| ▸ | HTR3B | O95264 | 1/20 | 0.38 |
| ▸ | PRNP | P04156 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27699518 | 1.00 | — | — | |
| SCHEMBL7029723 | 0.93 | ALOX15 (0.46) | ALOX15ALDH1A1TSHRPIM1LMNA | |
| SCHEMBL7644458 | 0.91 | ALOX15 (0.45) | ALOX15ALDH1A1TSHRPIM1DNM1 | |
| SCHEMBL18871718 | 0.91 | ALOX15 (0.45) | ALOX15ALDH1A1TSHRPIM1DRD2 | |
| SCHEMBL7649942 | 0.90 | HRH3 (0.52) | ALOX15ALDH1A1TSHRHRH3MAPT | |
| SCHEMBL25106441 | 0.89 | ALOX15 (0.56) | ALOX15PIM1SMN1; SMN2 | |
| SCHEMBL18402524 | 0.89 | ALOX15 (0.44) | ALOX15ALDH1A1TSHRPIM1HRH3 | |
| SCHEMBL19524668 | 0.89 | GNAI3 (0.53) | ALOX15ALDH1A1TSHRPIM1HRH3 | |
| SCHEMBL12443471 | 0.89 | ALOX15 (0.44) | ALOX15ALDH1A1TSHRPIM1HRH3 | |
| SCHEMBL27354498 | 0.89 | KEAP1 (0.48) | ALOX15PIM1CYP2D6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338411-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | RECODE THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| WO-2023141576-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | POSEIDA THERAPEUTICS, INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2022169508-A1 | UNSATURATED DENDRIMERS COMPOSITIONS,RELATED FORMULATIONS, AND METHODS OF USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-08-11 | — | — | WO | disclosed |
| US-5283364-A | Hydrolysis of isocyanates with water in presence of amide solvent | BAYER AKTIENGESELLSCHAFT (DE) | 1994-02-01 | — | — | US | disclosed |
| EP-0255677-B1 | Process for producing Polyamino-hydroxy compounds containing urethane and/or urea groups and their use in the production of polyurea urethanes | BAYER AG (DE) | 1993-12-08 | — | — | EP | disclosed |
| US-4970342-A | ONE STEP HYDROLYSIS OF ISOCYANATE GROUP CONTAINING COMPOUNDS IN PRESENCE OF EXCESS WATER AND TERTIARY AMINE CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1990-11-13 | — | — | US | disclosed |
| EP-0255677-A1 | Process for producing Polyamino-hydroxy compounds containing urethane and/or urea groups and their use in the production of polyurea urethanes | BAYER AG (DE) | 1988-02-10 | — | — | EP | disclosed |
| EP-0097298-B1 | POLYAMINES, PROCESS FOR PRODUCING POLYAMINES AND THEIR USE IN THE PRODUCTION OF POLYURETHANES | BAYER AG (DE) | 1986-04-30 | — | — | EP | disclosed |
| US-4501873-A | USING BASIC CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1985-02-26 | — | — | US | disclosed |
| EP-0113020-A1 | Reaction components containing amino groups, process for their preparation and their use | BAYER AG (DE) | 1984-07-11 | — | — | EP | disclosed |
| US-4291151-A | Process for preparing polycarbonate using cyclic di- or triamine catalyst | GENERAL ELECTRIC COMPANY (US) | 1981-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338411-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | CHMP4B, LIPA, NPC1L1 | ALOX15 1932/4885ALDH1A1 4006/4885TSHR 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.